MedTrace Logo

Evaluation of a Digiphysical Screening Method to Identify and Diagnose Familial Hypercholesterolemia

NCT04929457 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 30000

Last updated 2023-03-16

No results posted yet for this study

Summary

Longitudinal and observational registry-based cohort study of individuals participating in the national digiphysical screening program for Familial Hypercholesterolemia. The information collected in the screening process will be combined in pseudo-anonymous form with data from the National Board of Health and Welfare (registries: Cause of Death, Diagnoses according to International Classification of Diseases (ICD) and Prescribed drugs) and Statistic Sweden (Longitudinal integrated database for health insurance and labour market studies). Primary analysis: association between Familial Hypercholesterolemia and cardiovascular disease. Secondary analysis: efficacy and health economic aspects of digiphysical screening for Familial Hypercholesterolemia.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Jonas Brinck, MD PhD · Dept. of Medicine Huddinge H7, Karolinska Institute, Stockholm

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2031-09-30
Completion
2033-09-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04929457 on ClinicalTrials.gov